Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Los, F. J.
Right arrow Articles by van den Berg, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Los, F. J.
Right arrow Articles by van den Berg, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.10, No.1 pp.79-94, 2004
© European Society of Human Reproduction and Embryology 2004; all rights reserved

The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model

Frans J. Los1, Diane Van Opstal and Cardi van den Berg

Department of Clinical Genetics, Erasmus Medical Centre, P.O.Box 1738, NL-3000 DR Rotterdam, The Netherlands 1 To whom correspondence should be addressed. e-mail: f.j.los{at}erasmusmc.nl

Assisted reproduction and preimplantation genetic diagnosis (PGD) involve various complicated techniques, each of them with its own problems. However, the greatest problem with PGD for chromosome abnormalities is not of a technical nature but is a biological phenomenon: chromosomal mosaicism in the cleavage stage embryo. Here, we present a hypothetical, quantitative model for the development of chromosomally normal, abnormal and mosaic embryos. The arising of mosaicism in 2–8-cell embryos was described by a binomial probability model on the occurrence of mitotic events inducing chromosomal changes in the blastomeres. This model converted the ‘mean’ rate of mosaicism found in cross-sectional studies (60%) into an equal rate of mosaic embryos at arrival at the 8-cell stage (59.8%). The disappearance of >90% of the mosaic embryos or the mosaicism itself from surviving embryos during the morula stage was explained by mitotic arrest of most of the mitotically changed cells under increasing cell cycle control. In our model, 25.9 and 14.3% of the embryos at the 8-cell stage are normal and abnormal respectively. The remaining 59.8% of the embryo shows mosaicism: 34.6% of abnormal/normal cells and 25.2% of abnormal/abnormal cells. The high proportion of abnormal and mosaic embryos together explains the high rate of abnormal laboratory findings in PGD for chromosomal abnormalities and aneuploidy screening. The poor representation of a 1- or 2-cell biopsy for the 7- or 6-cell post-biopsy embryo in the case of mosaicism explains the high rate of false-negative and false-positive results.

Key words: chromosomal mosaicism/embryo/model/preimplantation genetic diagnosis/uniparental disomy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
C. M.H. Combelles
What are the trade-offs between one-cell and two-cell biopsies of preimplantation embryos?
Hum. Reprod., March 1, 2008; 23(3): 493 - 498.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Donoso, C. Staessen, B.C.J.M. Fauser, and P. Devroey
Current value of preimplantation genetic aneuploidy screening in IVF
Hum. Reprod. Update, January 1, 2007; 13(1): 15 - 25.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Vialard, C. Petit, M. Bergere, D. M. Gomes, V. Martel-Petit, R. Lombroso, Y. Ville, H. Gerard, and J. Selva
Evidence of a high proportion of premature unbalanced separation of sister chromatids in the first polar bodies of women of advanced age
Hum. Reprod., May 1, 2006; 21(5): 1172 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.B. Baart, E. Martini, I. van den Berg, N.S. Macklon, R-J.H. Galjaard, B.C.J.M. Fauser, and D. Van Opstal
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF
Hum. Reprod., January 1, 2006; 21(1): 223 - 233.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Gutierrez-Mateo, L. Gadea, J. Benet, D. Wells, S. Munne, and J. Navarro
Aneuploidy 12 in a Robertsonian (13;14) carrier: Case report
Hum. Reprod., May 1, 2005; 20(5): 1256 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Staessen, P. Platteau, E. Van Assche, A. Michiels, H. Tournaye, M. Camus, P. Devroey, I. Liebaers, and A. Van Steirteghem
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial
Hum. Reprod., December 1, 2004; 19(12): 2849 - 2858.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.